PROGYNY, INC. (PGNY) News

PROGYNY, INC. (PGNY): $15.44

0.47 (+3.14%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

B

Add PGNY to Watchlist
Sign Up

Industry: Medical - Services

Industry

C

Ranked

#39 of 63

in industry

Filter PGNY News Items

PGNY News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

PGNY News Highlights

  • For PGNY, its 30 day story count is now at 3.
  • Over the past 5 days, the trend for PGNY's stories per day has been choppy and unclear. It has oscillated between 1 and 2.

Latest PGNY News From Around the Web

Below are the latest news stories about PROGYNY INC that investors may wish to consider to help them evaluate PGNY as an investment opportunity.

Executive Chairman David Schlanger Sells 162,906 Shares of Progyny Inc (PGNY)

On December 22, 2023, Executive Chairman David Schlanger sold 162,906 shares of Progyny Inc (NASDAQ:PGNY), as reported in a recent SEC Filing.

Yahoo | December 24, 2023

24 Countries With Biggest Population Decline

This article will list countries where population is continuously decreasing and highlight the major reasons behind this population decline. You can skip our detailed overview of the world’s population patterns and read 10 Countries With Biggest Population Decline. Recent estimates from the United Nations predict that the global population will reach approximately 8.5 billion by 2030, expand […]

Yahoo | December 19, 2023

4 Unstoppable Multibaggers to Buy in 2024 and Hold for the Next Decade

Even after posting solid results so far in 2023, these four stocks still offer long-term multibagger potential.

Yahoo | December 19, 2023

Returns On Capital Are Showing Encouraging Signs At Progyny (NASDAQ:PGNY)

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

Yahoo | December 4, 2023

Does Progyny (PGNY) have a Long Runway for Growth?

Polen Capital, an investment management company, released its “Polen Global SMID Company Growth Strategy” third-quarter 2023 investor letter. A copy of the same can be downloaded here. The fund returned -6.59% gross and -6.64% net of fees compared to -3.55% return for the MSCI ACWI SMID Capitalization Index. Negative security selection drove the underperformance of the […]

Yahoo | November 20, 2023

Progyny (PGNY) is an Incredible Growth Stock: 3 Reasons Why

Progyny (PGNY) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Yahoo | November 13, 2023

Progyny, Inc. to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

NEW YORK, Nov. 10, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced that Pete Anevski, Progyny’s Chief Executive Officer, and Mark Livingston, Chief Financial Officer, will participate in a fireside chat at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on Thursday, November 16, 2023, at 10:30 A.M. Eastern Time. A live audiocast and replay

Yahoo | November 10, 2023

Progyny, Inc. (NASDAQ:PGNY) Q3 2023 Earnings Call Transcript

Progyny, Inc. (NASDAQ:PGNY) Q3 2023 Earnings Call Transcript November 7, 2023 Progyny, Inc. beats earnings expectations. Reported EPS is $0.16, expectations were $0.11. Operator: Good day, everyone, and welcome to the Progyny, Inc. Third Quarter 2023 Earnings Call. [Operator Instructions] It is now my pleasure to turn the floor over to your host, James Hart. […]

Yahoo | November 9, 2023

Progyny Inc (PGNY) Posts Record Revenue in Q3 2023, Raises Full-Year Guidance

Robust Growth and Client Expansion Drive Progyny's Performance

Yahoo | November 7, 2023

Progyny, Inc. Announces Third Quarter 2023 Results

Record Quarterly Revenue of $280.9 Million, Reflecting 37% Growth Over the Prior Year PeriodRaises Full Year Revenue and Earnings GuidanceStrong Sales Season Produces 1.3 Million New Covered Lives NEW YORK, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a leading benefits management company specializing in fertility and family building benefits solutions, today announced its financial results for the three-month period ended September 30, 2023 (“the

Yahoo | November 7, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!